• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在血管活性肠肽(VIP)、垂体腺苷酸环化酶激活肽(PACAP)和促胰液素中引入精氨酸16对配体与受体亲和力的影响。

Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors.

作者信息

Gourlet P, Vandermeers A, Vandermeers-Piret M C, De Neef P, Waelbroeck M, Robberecht P

机构信息

Department of Biochemistry and Nutrition, Faculty of Medicine, Université Libre de Bruxelles, Belgium.

出版信息

Biochim Biophys Acta. 1996 Dec 12;1314(3):267-73. doi: 10.1016/s0167-4889(96)00106-1.

DOI:10.1016/s0167-4889(96)00106-1
PMID:8982281
Abstract

Rabbit secretin, which differs from all other mammalian secretins in having a Leu residue in position 6 (instead of Phe) and a basic residue (Arg) in position 16, had a lower affinity than porcine secretion on recombinant rat secretin receptors but had a greater affinity than porcine secretin on recombinant rat VIP1 and PACAP I receptors. Synthetic [L6] porcine secretin had a reduced potency on secretin and VIP1 receptors whereas [R16] porcine secretin had a similar binding profile as rabbit secretin. Thus, an arginine residue in position 16 reduced 3-fold the affinity of secretin for secretin receptors but increased 30-fold its affinity for the VIP1 and PACAP I receptors. The introduction of an arginine residue in position 16, instead of glutamine, in VIP and PACAP had a similar effect: [R16] VIP and [R16] PACAP had 3- to 10-fold higher affinities than VIP and PACAP for VIP1 and PACAP I receptors, and 3-fold lower affinities for the secretin receptors. The three [R16] peptides also had a reduced potency on the chimeric receptor consisting of the N-terminal part of the secretin receptor grafted on the VIP1 receptor, and an enhanced potency on the chimeric receptor consisting of the N-terminal part of VIP1 receptor grafted on the secretin receptor, indicating that position 16 of each ligand interacted with the N-terminal extracellular domain of the receptors.

摘要

兔促胰液素在第6位氨基酸残基为亮氨酸(而非苯丙氨酸),第16位为碱性氨基酸残基(精氨酸),这与所有其他哺乳动物促胰液素不同。在重组大鼠促胰液素受体上,兔促胰液素的亲和力低于猪促胰液素,但在重组大鼠VIP1和PACAP I受体上,其亲和力高于猪促胰液素。合成的[L6]猪促胰液素对促胰液素和VIP1受体的效力降低,而[R16]猪促胰液素的结合特征与兔促胰液素相似。因此,第16位的精氨酸残基使促胰液素对促胰液素受体的亲和力降低了3倍,但使其对VIP1和PACAP I受体的亲和力增加了30倍。在VIP和PACAP的第16位引入精氨酸残基(而非谷氨酰胺)有类似效果:[R16] VIP和[R16] PACAP对VIP1和PACAP I受体的亲和力比VIP和PACAP高3至10倍,对促胰液素受体的亲和力低3倍。这三种[R16]肽对由嫁接到VIP1受体上的促胰液素受体N端部分组成的嵌合受体的效力也降低,而对由嫁接到促胰液素受体上的VIP1受体N端部分组成的嵌合受体的效力增强,表明每个配体的第16位与受体的N端细胞外结构域相互作用。

相似文献

1
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors.在血管活性肠肽(VIP)、垂体腺苷酸环化酶激活肽(PACAP)和促胰液素中引入精氨酸16对配体与受体亲和力的影响。
Biochim Biophys Acta. 1996 Dec 12;1314(3):267-73. doi: 10.1016/s0167-4889(96)00106-1.
2
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.促胰液素8-15位氨基酸残基与促胰液素受体N端结构域的相互作用。
Eur J Biochem. 1996 Jul 15;239(2):349-55. doi: 10.1111/j.1432-1033.1996.0349u.x.
3
Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.大鼠松果体中血管活性肠肽/垂体腺苷酸环化酶激活肽受体的药理学、分子及功能特性
Neuroscience. 1998 Aug;85(3):887-96. doi: 10.1016/s0306-4522(97)00668-4.
4
Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes.第22位的血管活性肠肽修饰可区分受体亚型。
Eur J Pharmacol. 1998 May 1;348(1):95-9. doi: 10.1016/s0014-2999(98)00133-2.
5
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.血管活性肠肽(VIP)、蛙皮素和垂体腺苷酸环化酶激活肽(PACAP)的类似物可区分大鼠和人类的VIP1和VIP2受体。
Ann N Y Acad Sci. 1998 Dec 11;865:247-52. doi: 10.1111/j.1749-6632.1998.tb11184.x.
6
Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.垂体腺苷酸环化酶激活多肽I和II受体、血管活性肠肽1以及嵌合氨基末端垂体腺苷酸环化酶激活多肽/血管活性肠肽1受体的特性:多种受体状态的证据
Mol Pharmacol. 1996 Dec;50(6):1596-604.
7
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides. 1996;17(5):825-9. doi: 10.1016/0196-9781(96)00107-6.
8
Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
Ann N Y Acad Sci. 1998 Dec 11;865:386-9. doi: 10.1111/j.1749-6632.1998.tb11201.x.
9
Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors.亲脂性血管活性肠肽衍生物与重组血管活性肠肽1/垂体腺苷酸环化酶激活肽及血管活性肠肽2/垂体腺苷酸环化酶激活肽受体的相互作用
Eur J Pharmacol. 1998 Jul 31;354(1):105-11. doi: 10.1016/s0014-2999(98)00435-x.
10
The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.垂体腺苷酸环化酶激活多肽(PACAP I)和血管活性肠肽(PACAP II VIP1)受体通过与不同G蛋白相互作用,刺激转染的CHO细胞中肌醇磷酸的合成。
Biochim Biophys Acta. 1997 Jun 27;1357(2):249-55. doi: 10.1016/s0167-4889(97)00028-1.

引用本文的文献

1
Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.人类血管活性肠肽受体第一个跨膜螺旋中的两个酪氨酸残基在维持活性构象方面发挥作用。
Br J Pharmacol. 2002 Aug;136(7):1042-8. doi: 10.1038/sj.bjp.0704802.
2
Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.一种新型VPAC(1)选择性激动剂的表征以及参与羧基末端肽识别的受体结构域的鉴定。
Br J Pharmacol. 2000 Jun;130(4):819-26. doi: 10.1038/sj.bjp.0703384.